Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Order Forms
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Peer-reviewed Publications
Utility of Circulating Tumor DNA in Appendiceal Tumors

Utility of Circulating Tumor DNA in Appendiceal Tumors

Bhutiani M, Helmink BA, Zeineddine M, et al. Journal of Gastrointestinal Surgery. 2023

Previous Resource

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma

Azzi G, Tavallai M, Aushev VA, et al. The Oncologist. 2023
Next Resource

Role of Tumor-informed Personalized ctDNA Assay in Informing Recurrence in Patients with Peritoneal Metastases from Colorectal

Dhiman A, Kothary V, Witmer HD, et al. Annals of Surgery. 2023

Related Content

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Nederlof et al, Nature Medicine 2024

Read Publication
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases

Kataoka et al, Ann Oncol 2024

Read Publication
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Nakamura, et al. Nature Medicine 2024

Read Publication
12 days ago
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Pr

Akaike T, Thakuria M, Silk AW, et al. J Clin Oncol. 2024

Read Publication
13 days ago
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma

Hanna GJ, Dennis MJ, Scarfo N, et al., Clinical Cancer Research. 2024

Read Publication
14 days ago
Donor-derived Cell-free DNA is a Valuable Monitoring Tool after Single Lung Transplantation: Multi-center Analysis

Arunachalam, Ambalavanan et al., JHLT Open, Volume 0, Issue 0, 100155

Read Publication
about 1 month ago
Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group

Read Publication
about 1 month ago
Kidney transplantation in adults: Clinical features and diagnosis of acute kidney allograft rejection

Read Publication
2 months ago
Hereditary cancer testing in a diverse sample across three breast imaging centers

Westbrook, L. et al. Breast Cancer Research and Treatment 2023

Read Publication
Evaluating threshold for donor fraction cell-free DNA using clinically available assay for rejection in pediatric and adult heart transplant

Deshpande et al. 2024 Pediatric Transplantation

Read Publication
Comparing Plasma Donor–derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study

Halloran et al. 2024 Transplantation

Read Publication
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer

Shaw, et al. ASCO Pubs, 2024

Read Publication
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024

Bromberg, et al. Transplantation 2024

Read Publication
Personalized tumor-informed circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients rece

Oh, et al. Thorac Cancer. 2024;1–8.

Read Publication
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma

Rachel A. Fischer, et al. Critical Reviews in Oncology 2024

Read Publication
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detec

Aaron C. Tan, et al. Cancer, 2024

Read Publication
Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States

Halloran, et al. Transplantation 2023

Read Publication
Impact of high‐risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from t

Martin et al. 2023 Prenat. Diagn

Read Publication
Validation of an Enhanced Version of a Single- Nucleotide Polymorphism-Based Noninvasive Prenatal Test for Detection of Fetal Aneuploidies

Ryan A, Hunkapiller N, Banjevic M, et al. Fetal Diagn Ther 2016

Read Publication
Informatics-based, highly accurate, noninvasive prenatal paternity testing

Ryan A, Baner J, Demko Z, et al. Genet Med 2013

Read Publication

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.